Artificial intelligence for triple-negative breast cancer from imaging to multi-omics - Takeaways - MDSpire

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

  • By

  • Xing Peng

  • Xinyu Zhou

  • Xin Feng

  • Nimin Fang

  • Xiaoya Dong

  • Wanjing Hong

  • Tianli Li

  • Renxing Li

  • Mohammad Faidzul Nasrudin

  • June 30, 2026

  • 0 min

Share

  • 1

    Triple-negative breast cancer (TNBC) lacks robust biomarkers for diagnosis and treatment-response assessment due to its aggressive and heterogeneous nature.

  • 2

    Artificial intelligence (AI) is increasingly utilized in TNBC for analyzing imaging, digital pathology, and molecular data.

  • 3

    AI applications in TNBC include lesion segmentation, subtype classification, and prediction of treatment response and survival.

  • 4

    Current AI studies in TNBC face limitations such as small cohorts, inconsistent definitions, and inadequate external validation.

  • 5

    Future advancements in AI for TNBC will depend on multi-institutional data curation and reliable multimodal designs.

Original Source(s)

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

  • by Xing Peng, Xinyu Zhou, Xin Feng, Nimin Fang, Xiaoya Dong, Wanjing Hong, Tianli Li, Renxing Li, Mohammad Faidzul Nasrudin

  • June 30, 2026

Related Content

Case Report: Primary sporadic intramedullary malignant peripheral nerve sheath tumor with intracranial extension and a subpial nodule suggestive of early dissemination

Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report

BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China